HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations

被引:14
作者
Borner, K
Hartwig, H
Leitzke, S
Hahn, H
Müller, RH
Ehlers, S
机构
[1] Free Univ Berlin, Benjamin Franklin Univ Clin, Inst Clin Chem & Pathobiochem, D-12000 Berlin, Germany
[2] Free Univ Berlin, Inst Infect Med, D-12000 Berlin, Germany
[3] Free Univ Berlin, Inst Pharmaceut Technol, D-12000 Berlin, Germany
[4] Res Ctr Borstel, Div Mol Infect Biol, Berlin, Germany
关键词
clofazimine; nanosuspensions; HPLC; tissue concentrations;
D O I
10.1016/S0924-8579(98)00065-X
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
A simple HPLC method is described for the determination of clofazimine in mouse tissues and in serum. The main application of the method was the determination of the drug in mouse tissues after i.v. administration of nanocrystalline suspensions or liposomal encapsulated clofazimine. Tissues were extracted with a 10-fold (w/v) volume of an extraction solution consisting of methanol/glacial acetic acid 9:1 (v/v). Serum proteins were precipitated with a 2-fold volume of acetonitrile. Isocratic chromatography was performed using an anion exchange column (Nucleosil 100-5 SA, Macherey & Nagel) for separation. The mobile phase was a mixture of acetonitrile and 0.1 mol/l aqueous phosphoric acid (75:25, v/v), adjusted to pH 2.9 with sodium hydroxide solution. Absorption of the eluate was monitored at 495 nm. The assay was precise, simple to perform and fast. Recovery from tissues was greater than or equal to 98%, from nanoparticles greater than or equal to 98%, and from liposomes greater than or equal to 96%. No interference was observed in extracts from mouse liver, spleen, lungs and human serum. (C) 1999 Published by Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 8 条
[1]
SINGLE BILAYER LIPOSOMES PREPARED WITHOUT SONICATION [J].
BATZRI, S ;
KORN, ED .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 298 (04) :1015-1019
[2]
DETERMINATION OF THREE MAIN ANTI-LEPROSY DRUGS AND THEIR MAIN METABOLITES IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
GIDOH, M ;
TSUTSUMI, S ;
TAKITANI, S .
JOURNAL OF CHROMATOGRAPHY, 1981, 223 (02) :379-392
[3]
KRISHNAN TR, 1992, INT J LEPROSY, V60, P549
[4]
MAMIDI NVSR, 1995, ARZNEIMITTEL-FORSCH, V45-2, P1029
[5]
Nanosuspensions for the formulation of poorly soluble drugs - I. Preparation by a size-reduction technique [J].
Muller, RH ;
Peters, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (02) :229-237
[6]
Determination of serum and tissue levels of phenazines including clofazimine [J].
OConnor, R ;
OSullivan, JF ;
OKennedy, R .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (02) :307-315
[7]
DETERMINATION OF CLOFAZIMINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
PETERS, JH ;
HAMME, KJ ;
GORDON, GR .
JOURNAL OF CHROMATOGRAPHY, 1982, 229 (02) :503-508
[8]
PETERS S, 1998, 2 WORLD M PHARM BIOP